154 related articles for article (PubMed ID: 3301179)
21. Drug therapy reviews: clinical pharmacology of antiepileptic drugs.
Browne TR
Am J Hosp Pharm; 1978 Sep; 35(9):1048-56. PubMed ID: 358830
[TBL] [Abstract][Full Text] [Related]
22. Nonparametric population modeling of valproate pharmacokinetics in epileptic patients using routine serum monitoring data: implications for dosage.
Bondareva IB; Jelliffe RW; Sokolov AV; Tischenkova IF
J Clin Pharm Ther; 2004 Apr; 29(2):105-20. PubMed ID: 15068399
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic drug monitoring: improved performance through educational intervention.
D'Angio RG; Stevenson JG; Lively BT; Morgan JE
Ther Drug Monit; 1990 Mar; 12(2):173-81. PubMed ID: 2315974
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic drug monitoring of cancer chemotherapy.
Alnaim L
J Oncol Pharm Pract; 2007 Dec; 13(4):207-21. PubMed ID: 18045780
[TBL] [Abstract][Full Text] [Related]
25. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
26. The relevance of clinical pharmacokinetics and therapeutic drug monitoring: anticonvulsant mood stabilizers and antipsychotics.
Janicak PG
J Clin Psychiatry; 1993 Sep; 54 Suppl():35-41; discussion 55-6. PubMed ID: 8104932
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic drug monitoring of tricyclic antidepressants: how does it work under clinical conditions?
Müller MJ; Dragicevic A; Fric M; Gaertner I; Grasmäder K; Härtter S; Hermann E; Kuss HJ; Laux G; Oehl W; Rao ML; Rollmann N; Weigmann H; Weber-Labonte M; Hiemke C
Pharmacopsychiatry; 2003 May; 36(3):98-104. PubMed ID: 12806567
[TBL] [Abstract][Full Text] [Related]
28. [TDM (therapeutic drug monitoring) for dosing theophylline].
Ueda W
Masui; 1991 Oct; 40(10):1536-41. PubMed ID: 1766103
[TBL] [Abstract][Full Text] [Related]
29. [The origin of informed consent].
Mallardi V
Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
[TBL] [Abstract][Full Text] [Related]
30. Choosing optimal sampling times for therapeutic drug monitoring.
Schumacher GE
Clin Pharm; 1985; 4(1):84-92. PubMed ID: 3971691
[TBL] [Abstract][Full Text] [Related]
31. Meta-analysis of research on the effect of clinical pharmacokinetics services on therapeutic drug monitoring.
Ried LD; McKenna DA; Horn JR
Am J Hosp Pharm; 1989 May; 46(5):945-51. PubMed ID: 2729302
[TBL] [Abstract][Full Text] [Related]
32. [Monitoring of therapy using drug concentration levels: Why? When? How?].
Vozeh S
Ther Umsch; 1990 Aug; 47(8):635-9. PubMed ID: 2218964
[TBL] [Abstract][Full Text] [Related]
33. Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients.
Berge M; Guillemain R; Boussaud V; Pham MH; Chevalier P; Batisse A; Amrein C; Dannaoui E; Loriot MA; Lillo-Le Louet A; Billaud EM
Transpl Infect Dis; 2009 Jun; 11(3):211-9. PubMed ID: 19302272
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic drug monitoring for optimizing amisulpride therapy in patients with schizophrenia.
Müller MJ; Regenbogen B; Härtter S; Eich FX; Hiemke C
J Psychiatr Res; 2007 Oct; 41(8):673-9. PubMed ID: 16324716
[TBL] [Abstract][Full Text] [Related]
35. AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011.
Hiemke C; Baumann P; Bergemann N; Conca A; Dietmaier O; Egberts K; Fric M; Gerlach M; Greiner C; Gründer G; Haen E; Havemann-Reinecke U; Jaquenoud Sirot E; Kirchherr H; Laux G; Lutz UC; Messer T; Müller MJ; Pfuhlmann B; Rambeck B; Riederer P; Schoppek B; Stingl J; Uhr M; Ulrich S; Waschgler R; Zernig G
Pharmacopsychiatry; 2011 Sep; 44(6):195-235. PubMed ID: 21969060
[TBL] [Abstract][Full Text] [Related]
36. The development of a drug measurement service at St. Paul's Hospital: a pharmacy perspective.
Ensom RJ; Godwin CC; Nakagawa RS
Can J Hosp Pharm; 1982; 35(5):135-42. PubMed ID: 10258990
[TBL] [Abstract][Full Text] [Related]
37. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
38. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
Sneed RC; May WL; Stencel C
Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
[TBL] [Abstract][Full Text] [Related]
39. Pharmacologic principles of cardiovascular drug administration to the critically ill.
Campbell S
Crit Care Clin; 1985 Nov; 1(3):471-90. PubMed ID: 3916790
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic drug monitoring for drugs used in the treatment of substance-related disorders: literature review using a therapeutic drug monitoring appropriateness rating scale.
Brünen S; Vincent PD; Baumann P; Hiemke C; Havemann-Reinecke U
Ther Drug Monit; 2011 Oct; 33(5):561-72. PubMed ID: 21912330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
